BEGIN:VCALENDAR
VERSION:2.0
PRODID:-// - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://futurebloodtesting.org
X-WR-CALDESC:Events for 
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20241015T120000
DTEND;TZID=Europe/London:20241015T130000
DTSTAMP:20260504T103302
CREATED:20240930T105934Z
LAST-MODIFIED:20241011T144659Z
UID:1894-1728993600-1728997200@futurebloodtesting.org
SUMMARY:Alzheimer’s disease Diagnosis and Plasma phospho-tau217-the ADAPT study
DESCRIPTION:Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-10-15 \n\nAbstract: Exciting progress is being made in the early and accurate detection of Alzheimer’s disease (AD) using blood tests. The most promising of these blood markers is plasma p-tau217. Dr Ashvini Keshavan will first review the evidence for concordance of plasma p-tau217 with gold standard Alzheimer’s disease biomarkers (i.e. amyloid positron emission tomography and cerebrospinal fluid tests) and the current state of commercial availability of plasma phosphorylated tau biomarkers including comparisons of effect sizes. She will then proceed with describing the plan for ADAPT\, a three-stage study including a UK multi-centre randomised controlled trial of disclosure of plasma p-tau217 results to patients and clinicians. From this study she aims to find out whether plasma p-tau217 helps to diagnose AD more quickly\, more accurately and at an earlier disease stage in comparison to routine memory clinic diagnostic pathways\, and we will obtain evidence for its cost effectiveness and acceptability to patients.\n\nBio: Dr Ashvini Keshavan is a senior clinical research fellow and honorary consultant neurologist at the Dementia Research Centre\, UCL Queen Square Institute of Neurology. A graduate of Trinity College\, Cambridge\, she completed postgraduate neurology training in London\, and obtained her PhD in 2019 on Cerebrospinal fluid and blood biomarkers of Alzheimer’s disease. Her ongoing work examines these biomarkers in clinical and pre-clinical cohorts\, aiming toward future application in more real-world settings\, serving diverse populations. She is the joint primary investigator for the UK-wide ADAPT (Alzheimer’s disease Diagnosis and Plasma p-Tau217) study.\n\nThis webinar is part of the 2024 Future Blood Testing Network+ webinar series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
URL:https://futurebloodtesting.org/event/alzheimers-disease-diagnosis-and-plasma-phospho-tau217-the-adapt-study/
LOCATION:Online
CATEGORIES:Online Event,Seminar
ATTACH;FMTTYPE=image/jpeg:https://futurebloodtesting.org/wp-content/uploads/2024/09/FBTN-Webinar-Ash-1.jpg
ORGANIZER;CN="Future Blood Testing Network+":MAILTO:info@futurebloodtesting.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240927T120000
DTEND;TZID=Europe/London:20240927T130000
DTSTAMP:20260504T103302
CREATED:20240903T145827Z
LAST-MODIFIED:20241011T115243Z
UID:1833-1727438400-1727442000@futurebloodtesting.org
SUMMARY:Democratising Healthcare Technology: The Role and Challenges of Participatory Design in Healthcare
DESCRIPTION:Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-09-27\n\nAbstract: In this talk\, Dr Stephen Lindsay will delve into the fundamental principles of participatory design\, focusing on its role in democratizing the development of healthcare technologies. He will begin by exploring the core definition of participatory design\, emphasizing its potential to empower users by involving them directly in the creation process. He will then contrast this approach with current Patient and Public Involvement and Engagement (PPIE) practices in the UK\, highlighting how participatory design extends beyond consultation to share decision-making in design. The talk will also examine the specific challenges of applying participatory design in healthcare\, navigating ethical considerations\, ensuring inclusivity\, and managing the complexities of working with vulnerable populations. Through case studies from his own work\, he will demonstrate how participatory design can overcome these challenges\, leading to more inclusive\, effective\, and ethically sound healthcare solutions\, and offering a critical perspective on the limitations of traditional PPIE approaches.\n\nBio: Dr Stephen Lindsay is a Lecturer in Digital Healthcare and HCI at Glasgow University. His research is cantered on participatory design\, particularly with marginalized groups such as older adults\, people living with dementia\, and individuals with brain injuries. Dr Lindsay believes that involving these under-heard voices in healthcare technology design not only fosters more ethical practices but also drives innovation. His work has addressed diverse areas\, including designing digital tools for older adults\, supporting less-literate diabetes patients in rural Pakistan\, and creating technologies that genuinely reflect patients’ needs and experiences. Through this approach\, Dr Lindsay contributes to the development of digital health tools that are both ethically sound and practically effective\, grounded in the lived experiences of those they aim to serve.\n\nThis webinar is part of the 2024 Future Blood Testing Network+ webinar series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
URL:https://futurebloodtesting.org/event/democratising-healthcare-technology-the-role-and-challenges-of-participatory-design-in-healthcare/
LOCATION:Online
CATEGORIES:Online Event,Seminar
ATTACH;FMTTYPE=image/png:https://futurebloodtesting.org/wp-content/uploads/2024/09/FBTN-Webinar-Stephen.png
ORGANIZER;CN="Future Blood Testing Network+":MAILTO:info@futurebloodtesting.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240503T120000
DTEND;TZID=Europe/London:20240503T130000
DTSTAMP:20260504T103302
CREATED:20240412T100455Z
LAST-MODIFIED:20241011T122659Z
UID:1545-1714737600-1714741200@futurebloodtesting.org
SUMMARY:A Radical Solution to the Visualization and Interaction with Timeline Structured Information: UHS Lifelines Electronic Patient Record Interface
DESCRIPTION:Register for this free teams webinar here: https://futurebloodtesting.org/events/2024-05-03\n\nAbstract: The ambitious NHS Digital Transformation Programme faces challenges in delivering efficient and intuitive information to health professionals. Since 2009\, we have worked as a small team at University Hospital Southampton (UHS) Clinical Data Estate. Using e-data visualisation principles and a highly agile and iterative approach with minimal financial resources\, we have developed a transformative approach to the Electronic Patient Record (EPR) interface.\n\nOn UHS Lifelines\, the timeframe is continuously incremental as new content accumulates. The interface opens near instantaneously in real time and documents from any time point are immediately accessible without scrolling through lists\, menus\, multiple frames and software subsystems\, and the clinical history can be read subliminally to a valuable degree from the icon patterns. Despite initial constraints\, the system evolved into a powerful application at the heart of UHS EPR. Additionally\, it led to other software solutions\, such as the SCR+ (Somerset Cancer Registry Enhanced) Multi-Disciplinary Team Module for cancer data management. We believe our approach has broad applicability beyond healthcare\, potentially benefiting various sectors. We therefore appreciate all opportunities for collaboration to expand the project’s impact nationally and beyond.\n\nBio: Mr David Rew is a Consultant General Surgeon in Southampton\, Honorary Surgeon to the Faculty of Medicine of the University of Southampton and Visiting Professor in Clinical Informatics to Southampton Solent University. He served as the Editor in Chief of the European Journal of Surgical Oncology from 2003 to 2009. Since 2009\, he has held the position of global Subject Chair for Medicine on the SCOPUS Content Selection Advisory Board\, where he has appraised approximately 3\,500 clinical journals. Mr Rew claims no specialist knowledge in haematology\, blood testing or genomics\, beyond being up to date with his Statutory and Mandatory blood transfusion module in the hospital virtual learning environment. ​For the past 15 years\, David Rew has been the concept lead of a productive software development team at University Hospital Southampton\, creating radical solutions to the electronic patient record\, a whole-of-life breast cancer data set of more than 20\,000 records\, and a tool for the greater efficiency of cancer multidisciplinary teams\, all of which systems sit at the heart of the unique University Hospital Southampton Clinical Data Estate.\n\nThis webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
URL:https://futurebloodtesting.org/event/a-radical-solution-to-the-visualization-and-interaction-with-timeline-structured-information-uhs-lifelines-electronic-patient-record-interface/
LOCATION:Online
CATEGORIES:Online Event,Seminar
ATTACH;FMTTYPE=image/png:https://futurebloodtesting.org/wp-content/uploads/2024/04/Slide1.png
ORGANIZER;CN="Future Blood Testing Network+":MAILTO:info@futurebloodtesting.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240417T120000
DTEND;TZID=Europe/London:20240417T130000
DTSTAMP:20260504T103302
CREATED:20240318T161340Z
LAST-MODIFIED:20240321T163049Z
UID:1488-1713355200-1713358800@futurebloodtesting.org
SUMMARY:Rapid Blood Tests: The Two-Year Manifesto. Dr Martin Peacock  (Zimmer and Peacock Ltd)
DESCRIPTION:Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-04-17 \nAbstract: Zimmer and Peacock has worked on the development and manufacture of a platform intended to translate academic blood testing assays from the lab into the clinical setting\, and onto the market. At ZP\, for research to be impactful and sustainable\, it does need to be presented in a form factor so that it can be easily used by clinicians and patients. In this webinar and live streaming demo\, ZP will show how a scientific paper can easily become a clinical product. The policy at ZP is to translate science into regulatory approved products in 2 years or less. \nBio: Martin Peacock is an industrial bioelectrochemist with over twenty years of biosensor experience\, having had industrial roles from Abbott Diabetes to GSK\, and solving technical challenges from continuous glucose monitoring to RNA analysis. He is a Director at Zimmer and Peacock Ltd\, a company that sees sensors as a critical part of various social and commercial revolutions\, such as the Internet of Things (IoT)\, Sensor Web\, and the Invitro Diagnostics Market (IVD). With over eight years of experience in this role\, he lead a team of talented scientists and engineers who partner with academia and industry to develop and manufacture innovative sensors and medical diagnostics. \nThis webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
URL:https://futurebloodtesting.org/event/rapid-blood-tests-the-two-year-manifesto-dr-martin-peacock-zimmer-and-peacock-ltd/
LOCATION:Online
CATEGORIES:Online Event,Seminar
ATTACH;FMTTYPE=image/png:https://futurebloodtesting.org/wp-content/uploads/2024/03/FBTN-Webinar-Martin.png
ORGANIZER;CN="Future Blood Testing Network+":MAILTO:info@futurebloodtesting.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20240326T130000
DTEND;TZID=Europe/London:20240326T140000
DTSTAMP:20260504T103302
CREATED:20240311T153623Z
LAST-MODIFIED:20240311T161417Z
UID:1462-1711458000-1711461600@futurebloodtesting.org
SUMMARY:Routine cellular diagnostics: A platelet perspective? Dr Chris Jones (University of Reading)
DESCRIPTION:Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-03-26 \nAbstract: The idea of conducting tests for an infectious disease on the kitchen table would have seemed unimaginable only three years ago; now\, it is a routine part of life in the UK. Similarly\, measuring health markers such as heart rate or blood pressure used to involve a trip to your GP’s surgery; now\, they are measured by your watch.  Routine testing of cellular function may be the next step\, supplying data on cellular changes that occur before the presentation of symptoms or rapidly assessing the efficacy of therapies.  Platelets play a vital role in chronic and acute cardiovascular disease but also have roles in immunity\, inflammation\, cancer metastasis\, Alzheimer’s disease and infections\, such as dengue\, HIV-1\, malaria\, and COVID-19.  In addition\, they are easily obtained from subjects or patients\, making them valuable biomarkers for changes in blood vessels associated with disease\, ageing or therapy. This seminar will introduce the utility of platelets as a cellular biomarker and the progress we have made in designing tests that capture the function of these cells\, both in the lab and at point-of-care. \nBio: Chris Jones is an Associate Professor of the Thrombosis and Heamostasis in the school of Biological Sciences at the University of Reading. Over two decades\, he has designed and employed innovative platelet function assays to provide novel insights into platelet dysfunction. His lab has also developed analysis software for platelet activation assays and employed microfluidics\, open hardware and smartphone technology to develop low-cost point-of-care platelet function assays. These new technologies have led to HaemAnalytica\, a soon-to-be established spinout\, which will provide complete platelet function analysis for clinical trials and diagnostics. \nThis webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.
URL:https://futurebloodtesting.org/event/routine-cellular-diagnostics-a-platelet-perspective-dr-chris-jones-university-of-reading/
LOCATION:Online
CATEGORIES:Online Event,Seminar
ATTACH;FMTTYPE=image/png:https://futurebloodtesting.org/wp-content/uploads/2024/03/FBTN-Webinar-Chris.png
ORGANIZER;CN="Future Blood Testing Network+":MAILTO:info@futurebloodtesting.org
END:VEVENT
END:VCALENDAR